tiprankstipranks
Advertisement
Advertisement

nDatalyze Corp. Unveils Promising Clinical Study Outcomes

Story Highlights
nDatalyze Corp. Unveils Promising Clinical Study Outcomes

nDatalyze Corp (TSE:NDAT) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

nDatalyze Corp. reports that their innovative clinical study showcases promising results, indicating that their expert-guided approach to predicting depression probabilities outperforms standard machine learning methods. This breakthrough suggests potential for developing two distinct, cost-effective product pathways that leverage machine learning with minimal recalibration.

For further insights into TSE:NDAT stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1